A novel missense mutation in the second extracellular domain of GJB2, p.Ser183Phe, causes a syndrome of focal palmoplantar keratoderma with deafness.

Gap junctions, which consist of connexins, are intercellular channels that mediate rapid intercellular communication. In the skin, connexins are involved in the regulation of epidermal growth and differentiation. GJB2 encodes connexin26, which is an important skin-expressed gap junction protein. Mutations in GJB2 cause a wide variety of unique disorders, but despite extensive research, their mechanisms of action are poorly understood. The identification of novel diseases caused by mutations in GJB2 may help to illuminate the genotype-phenotype correlation and elucidate the function of different regions of the protein. Here, we report the first account of a family with a GJB2 missense mutation in the second extracellular domain (p.Ser183Phe) that causes skin abnormalities in addition to sensorineural hearing loss. Using fluorescent connexin26-EGFP fusion proteins, we showed that the mutation induces a partial protein transport defect that cannot be rescued by wild-type protein. Dye-transfer experiments using a parachute assay revealed channel functionality. Although p.Ser183Phe affects the second extracellular domain, mutations in the first extracellular domain also lead to focal palmoplantar keratoderma and likewise perturb protein transport in a dominant-negative manner. Therefore, we hypothesize that focal palmoplantar keratoderma in gap junction skin disease may be specifically associated with connexin trafficking defects as well as with mutations affecting its extracellular domains, thus broadening the spectrum of GJB2-associated diseases.

[1]  P. Steijlen,et al.  A novel missense mutation in GJB2 disturbs gap junction protein transport and causes focal palmoplantar keratoderma with deafness , 2007, Journal of Medical Genetics.

[2]  M. Steensel Gap junction diseases of the skin. , 2004 .

[3]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[4]  Y. Fujiyoshi,et al.  Roles of Met-34, Cys-64, and Arg-75 in the Assembly of Human Connexin 26 , 2003, The Journal of Biological Chemistry.

[5]  D. Laird,et al.  Life cycle of connexins in health and disease. , 2006, The Biochemical journal.

[6]  R D Horstmann,et al.  Pattern of connexin 26 (GJB2) mutations causing sensorineural hearing impairment in Ghana , 2001, Human mutation.

[7]  K. Arnos,et al.  Compound heterozygosity for dominant and recessive GJB2 mutations: Effect on phenotype and review of the literature , 2007, American journal of medical genetics. Part A.

[8]  M. Carella,et al.  Functional characterization of a novel Cx26 (T55N) mutation associated to non-syndromic hearing loss. , 2005, Biochemical and biophysical research communications.

[9]  M. Hodgins,et al.  A murine living skin equivalent amenable to live-cell imaging: analysis of the roles of connexins in the epidermis. , 2008, The Journal of investigative dermatology.

[10]  R. Errington,et al.  Multiple pathways in the trafficking and assembly of connexin 26, 32 and 43 into gap junction intercellular communication channels. , 2001, Journal of cell science.

[11]  D. Kelsell,et al.  A novel M163L mutation in connexin 26 causing cell death and associated with autosomal dominant hearing loss , 2008, Hearing Research.

[12]  T. Griffith,et al.  Effects of connexin‐mimetic peptides on gap junction functionality and connexin expression in cultured vascular cells , 2005, British journal of pharmacology.

[13]  G. Richard,et al.  Gap junctions: basic structure and function. , 2007, The Journal of investigative dermatology.

[14]  Andrew Forge,et al.  Mutations in the gene for connexin 26 (GJB2) that cause hearing loss have a dominant negative effect on connexin 30. , 2003, Human molecular genetics.

[15]  G. T. Cottrell,et al.  Functional consequences of heterogeneous gap junction channel formation and its influence in health and disease. , 2005, Biochimica et biophysica acta.

[16]  K. Willecke,et al.  Negative growth control of HeLa cells by connexin genes: connexin species specificity. , 1995, Cancer research.

[17]  D. Coviello,et al.  A novel dominant missense mutation – D179N – in the GJB2 gene (Connexin 26) associated with non‐syndromic hearing loss , 2003, Clinical genetics.

[18]  Luc Leybaert,et al.  The gap junction cellular internet: connexin hemichannels enter the signalling limelight. , 2006, The Biochemical journal.